The U.S. Food and Drug Administration approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older with achondroplasia and open epiphyses (growth plates), meaning these children still have the potential to grow. Achondroplasia is the most common form of dwarfism.
- Read more about FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/fda-approves-first-drug-to-improve-growth-in-children-with-most-common-form-of-dwarfism
No comments:
Post a Comment